Related Experiment Video

Updated: Jul 29, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

Evidence-based assessment of treatment options for children with IgA nephropathies

R J Wyatt1, R J Hogg

  • 1Le Bonheur Children's Medical Center and The Center for Health Policy , University of Tennessee Health Science Center, Memphis 38103, USA.

Pediatric Nephrology (Berlin, Germany)
|March 23, 2001
PubMed

Insights

Current treatments for IgA nephropathies in children lack high-level evidence. More rigorous randomized controlled trials are needed to establish effective therapies for idiopathic IgA nephropathy (IgAN) and Henoch-Schonlein purpura nephritis (HSPN).

Area of Science:

  • Pediatric Nephrology
  • Immunology
  • Clinical Evidence Evaluation

Background:

  • IgA nephropathies, including idiopathic IgA nephropathy (IgAN) and Henoch-Schonlein purpura nephritis (HSPN), are significant causes of kidney disease in children.
  • Current therapeutic strategies lack robust evidence from high-quality studies.

Purpose of the Study:

  • To critically evaluate existing evidence on therapeutic interventions for pediatric IgA nephropathies.
  • To identify outcome markers most relevant to predicting progressive renal failure.

Main Methods:

  • Systematic review and evidence-based evaluation of published studies on IgAN and HSPN treatments in children.
  • Focus on studies utilizing outcome markers strongly associated with renal failure progression.

Main Results:

  • No treatment for pediatric IgAN or HSPN has demonstrated efficacy through high-level evidence (Level 1 randomized controlled trials).
  • Some evidence supports corticosteroid use, but findings are conflicting.
  • No convincing evidence supports fish oil, ACE inhibitors, or tonsillectomy for these conditions.

Conclusions:

  • There is a critical need for well-designed randomized controlled trials in pediatric IgA nephropathies.
  • Current treatment approaches require further validation to ensure efficacy and safety in children.

More Related Videos

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury07:02

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury

Published on: February 10, 2026

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...